gestational age 14 weeks 6 days. Laboratory investigation showed a blood sugar of 98mg% and a normal complete hemogram, liver function test renal function test and coagulation profile. Anticardiolipin IgM and IgG antibody, Anti nuclear antibody (ANA) were positive. Anti Ds DNA antibody was negative. The diagnosis of antiphodpholipid antibody syndrome (APS) was confirmed as per standard criteria. 3 She was immediately put on Aspirin 150mg OD and unfractionated Heparin5000 unit BD. After one week her ApTT was 65 (normal 25 to 35 seconds).She was regularly followed-up with doppler study.
Doppler study of umbilical artery at 22 weeks showed decreased diastolic flow so dose of heparin increased to 5000 QID. At 26 weeks diastolic flow again decreased and heparin dose increased to 7500 QID. At 31 weeks doppler showed absent diastolic flow ( Figure 1 ) and aPTT and PT were normal. The dose heparin was titrated to 10000 unit QID and repeat doppler study at next day showed patent diastolic flow with Systolic Diastolic ratio 3.17 ( Figure 2 ). During this period patient didn't had any bleeding episodes. She was also given 1000mg calcium daily. At 34 weeks pregnancy was terminated by caesarean section because of fetal bradycardia. Baby was of 1.4kg and neonatal period was uneventful.
The mother was put on warfarin prophylaxis and at followup after 6 month she didn't have any thrombotic episodes and baby was developed up to age.
order to maintain target aPTT and intrauterine diastolic flow. The patient didn't have any bleeding episodes.
Available literature mentions about the use of heparin up to 20000 units per day in the management of APS but in this patient we have used heparin up to 40000 units daily. 6 We also gave high dose calcium (1000 mg) daily to prevent osteoporosis and she was followed up with regular checking of coagulation profile.
Spiros Dendrinos et al reported that low molecular weight heparin plus low-dose aspirin resulted in a higher live birth rate than intravenous immunoglobulin in the treatment of antiphospholipid antibody syndrome in women with recurrent abortion. 7 A recent intervention review by Marianne B Empson et al concludes that a combination of unfractionated heparin with aspirin may be helpful but there are potential side-effects for mothers. 6 Based on our report the dose of heparin needed for a successful outcome in pregnant ladies with APS should be individualized and should be titrated depending up on the clinical and investigation findings. Hence heparin can be used up to 40000 units per day in managing patients with APS without any bleeding episode provided strict monitoring of coagulation profile is done. 
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Discussion
The term "antiphospholipid syndrome" was first coined to denote the clinical association between antiphospholipid antibodies and a syndrome of hypercoagulability. 4, 5 Our patient had three unexplained IUD with aPL antibody and ANA positivity. The available literatures mention that aspirin and heparin are the treatment of choice but there are no clear cut guidelines for the dose of heparin. 2 In our patient we have started with 5000 unit heparin in twice daily dose but we had to increase the dose up to 10000 unit six hourly in
